A Multiple-Dose Study of LY3502970 in Healthy Participants
NCT05110794
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LY3502970
Sponsor
Eli Lilly and Company